ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...113114115116117118119120121122123...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment open:  COVidIVERmectin: Ivermectin for Treatment of Covid-19 (clinicaltrials.gov) -  Aug 12, 2020   
    P2,  N=102, Recruiting, 
    Not yet recruiting --> Recruiting
  • ||||||||||  Preclinical, Journal:  In vitro data of current therapies for SARS-CoV-2. (Pubmed Central) -  Aug 12, 2020   
    Not yet recruiting --> Recruiting Scientists all over the world should work together and increase their efforts in order to find feasible and efficient solutions against this new global viral threat.
  • ||||||||||  ceftriaxone / Generic mfg.
    Journal:  Strongyloides stercoralis as uncommon cause of ascitic fluid infection in cirrhosis (Pubmed Central) -  Aug 11, 2020   
    During the admission, he had fever and antibiotic treatment with ceftriaxone is started, for a urinary infection...The patient started antiparasitic treatment with ivermectin...This case shows the importance of diagnostic paracentesis in every cirrhotic patient. It is important to consider atypical presentation of Strongyloides infection in the immunocompromised host, considering it could be fatal without treatment.
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Pharmaceuticals in environment: the effect of ivermectin on ribwort plantain (Plantago lanceolata L.). (Pubmed Central) -  Aug 8, 2020   
    IVM accumulated in the roots and leaves of plants might negatively affect ecosystems due to its toxicity to herbivorous invertebrates. As IVM exposition increased the activity of catalase, the concentration of proline and polyphenols, as well as decreased the activity of ascorbate peroxidase and the concentration of the bioactive compounds acteoside and aucubin, long-term exposition of the ribwort plantain to IVM caused abiotic stress and might decrease the medicinal value of this herb.
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Ocular Changes After Ivermectin - (DOLF IVM/Oncho) (clinicaltrials.gov) -  Aug 8, 2020   
    P=N/A,  N=231, Completed, 
    As IVM exposition increased the activity of catalase, the concentration of proline and polyphenols, as well as decreased the activity of ascorbate peroxidase and the concentration of the bioactive compounds acteoside and aucubin, long-term exposition of the ribwort plantain to IVM caused abiotic stress and might decrease the medicinal value of this herb. Active, not recruiting --> Completed | Trial completion date: Aug 2021 --> Aug 2019 | Trial primary completion date: Aug 2021 --> Aug 2019
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study. (Pubmed Central) -  Aug 7, 2020   
    Active, not recruiting --> Completed | Trial completion date: Aug 2021 --> Aug 2019 | Trial primary completion date: Aug 2021 --> Aug 2019 Our modelling predictions suggest that ivermectin could be a valuable addition to the malaria control toolbox, both in areas with persistently high transmission where existing interventions are insufficient and in areas approaching elimination to prevent resurgence.
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion, Enrollment change:  Prophylactic Ivermectin in COVID-19 Contacts (clinicaltrials.gov) -  Aug 7, 2020   
    P2/3,  N=304, Completed, 
    Our modelling predictions suggest that ivermectin could be a valuable addition to the malaria control toolbox, both in areas with persistently high transmission where existing interventions are insufficient and in areas approaching elimination to prevent resurgence. Recruiting --> Completed | N=100 --> 304
  • ||||||||||  ivermectin / Generic mfg.
    Journal:  The Battle against COVID 19 Pandemic: What we Need to Know Before we "Test Fire" Ivermectin. (Pubmed Central) -  Aug 6, 2020   
    Being an available and affordable drug, enlisted in WHO List of Essential Medicine, and a long track record of clinical safety, the drug is already in clinical trials the world over. As the pandemic continues to ravage human civilisation with unabated intensity, the world eagerly waits for a ray of hope emanating from the outcome of the ongoing trials with ivermectin as well as other drugs.